Zhejiang Jingxin Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001K73
  • SHE: 002020
CNY
11.63
-0.12 (-1.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Zhejiang Jingxin Pharmaceutical Co., Ltd.

Why is Zhejiang Jingxin Pharmaceutical Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 3.97% and Operating profit at 7.28% over the last 5 years
2
Flat results in Mar 26
  • INTEREST(Q) At CNY 1.17 MM has Grown at inf%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 2.2 times
  • NET SALES(Q) Lowest at CNY 923.03 MM
3
With ROE of 12.44%, it has a very attractive valuation with a 1.46 Price to Book Value
  • Over the past year, while the stock has generated a return of 11.94%, its profits have risen by 1.5%
  • At the current price, the company has a high dividend yield of 0
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Zhejiang Jingxin Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Jingxin Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Zhejiang Jingxin Pharmaceutical Co., Ltd.
-43.79%
0.86
43.70%
China Shanghai Composite
3.23%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.97%
EBIT Growth (5y)
7.28%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.65
Tax Ratio
11.02%
Dividend Payout Ratio
38.05%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.44%
ROE (avg)
12.57%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.66
EV to EBIT
12.25
EV to EBITDA
9.38
EV to Capital Employed
1.77
EV to Sales
2.31
PEG Ratio
NA
Dividend Yield
2.27%
ROCE (Latest)
14.40%
ROE (Latest)
12.44%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 911.57 MM

DEBT-EQUITY RATIO (HY)

Lowest at -29.57 %

NET SALES(Q)

Highest at CNY 1,064.15 MM

-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 2.54 times

Here's what is working for Zhejiang Jingxin Pharmaceutical Co., Ltd.

Operating Cash Flow
Highest at CNY 911.57 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales
Highest at CNY 1,064.15 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio
Lowest at -29.57 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Depreciation
At CNY 75.73 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (CNY MM)

Here's what is not working for Zhejiang Jingxin Pharmaceutical Co., Ltd.

Inventory Turnover Ratio
Lowest at 2.54 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Footer loading